FPC Investment Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$500K Hold
1,910
– – 0.24% 23
2026
Q2
$486K Hold
1,910
– – 0.23% 23
2026
Q1
$380K Buy
1,910
+2
+0.1% +$444 0.19% 23
2025
Q4
$436K Hold
1,908
– – 0.24% 22
2025
Q3
$442K Hold
1,908
– – 0.27% 19
2025
Q2
$365K Sell
1,908
-307
-14% -$57.1K 0.23% 21
2025
Q1
$434K Buy
2,215
+2,097
+1,777% +$408K 0.3% 19
2024
Q4
$21.7K Buy
+118
New +$21.7K 0.02% 94

Other funds holding ABBV

FPC Investment Advisory's ABBV Position: Q3 2026 in Review

FPC Investment Advisory held its AbbVie (ABBV) position steady in Q3 2026 at 1,910 shares worth $500K. The position accounts for 0.24% of the portfolio, ranked #23.

FPC Investment Advisory first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • FPC Investment Advisory held 1,910 shares of AbbVie worth $500K as of Q3 2026.
  • FPC Investment Advisory left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.24% of FPC Investment Advisory's portfolio in Q3 2026, its #23 holding.
  • FPC Investment Advisory first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on FPC Investment Advisory's 13F filing for Q3 2026, filed 12 Nov 2026.